 David Root
Concepts (180)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Ventral Tegmental Area | 14 | 2026 | 63 | 6.790 |
Why?
| | Glutamic Acid | 12 | 2026 | 255 | 5.890 |
Why?
| | Neurons | 21 | 2026 | 1652 | 3.840 |
Why?
| | Vesicular Glutamate Transport Protein 2 | 8 | 2025 | 15 | 3.040 |
Why?
| | Cocaine | 12 | 2021 | 162 | 2.950 |
Why?
| | GABAergic Neurons | 6 | 2025 | 37 | 2.820 |
Why?
| | Dopamine | 8 | 2026 | 295 | 2.210 |
Why?
| | gamma-Aminobutyric Acid | 8 | 2025 | 194 | 1.950 |
Why?
| | Behavior, Animal | 11 | 2025 | 520 | 1.760 |
Why?
| | Reward | 5 | 2026 | 248 | 1.690 |
Why?
| | Septal Nuclei | 2 | 2025 | 24 | 1.670 |
Why?
| | Habenula | 6 | 2017 | 13 | 1.650 |
Why?
| | Globus Pallidus | 5 | 2019 | 25 | 1.590 |
Why?
| | Cocaine-Related Disorders | 7 | 2013 | 133 | 1.470 |
Why?
| | Avoidance Learning | 3 | 2025 | 63 | 1.460 |
Why?
| | Conditioning, Classical | 5 | 2025 | 119 | 1.420 |
Why?
| | Dopaminergic Neurons | 3 | 2026 | 68 | 1.210 |
Why?
| | Sucrose | 3 | 2025 | 114 | 1.090 |
Why?
| | Basal Forebrain | 2 | 2019 | 2 | 1.060 |
Why?
| | Motivation | 6 | 2021 | 602 | 1.040 |
Why?
| | Animals | 45 | 2026 | 38097 | 0.950 |
Why?
| | Behavior, Addictive | 2 | 2019 | 88 | 0.950 |
Why?
| | Vesicular Glutamate Transport Proteins | 1 | 2025 | 2 | 0.910 |
Why?
| | Self Administration | 12 | 2021 | 122 | 0.900 |
Why?
| | Action Potentials | 7 | 2014 | 502 | 0.880 |
Why?
| | Conditioning, Operant | 8 | 2025 | 94 | 0.880 |
Why?
| | Nucleus Accumbens | 4 | 2016 | 135 | 0.870 |
Why?
| | Vesicular Inhibitory Amino Acid Transport Proteins | 4 | 2025 | 10 | 0.810 |
Why?
| | Neural Pathways | 5 | 2024 | 317 | 0.790 |
Why?
| | Drug-Seeking Behavior | 3 | 2019 | 22 | 0.780 |
Why?
| | Rats | 22 | 2025 | 5585 | 0.780 |
Why?
| | Oxycodone | 2 | 2023 | 52 | 0.770 |
Why?
| | Mice | 15 | 2026 | 18355 | 0.750 |
Why?
| | Neuropeptides | 1 | 2021 | 75 | 0.690 |
Why?
| | Rats, Long-Evans | 13 | 2025 | 128 | 0.680 |
Why?
| | Cues | 7 | 2025 | 329 | 0.670 |
Why?
| | Synapses | 3 | 2024 | 439 | 0.660 |
Why?
| | Fear | 2 | 2022 | 368 | 0.630 |
Why?
| | Substance Abuse, Oral | 1 | 2019 | 1 | 0.610 |
Why?
| | Brain | 4 | 2022 | 2969 | 0.600 |
Why?
| | Glutamates | 1 | 2018 | 66 | 0.550 |
Why?
| | Image Processing, Computer-Assisted | 1 | 2022 | 782 | 0.520 |
Why?
| | Male | 34 | 2026 | 73003 | 0.520 |
Why?
| | Dopamine Uptake Inhibitors | 4 | 2013 | 59 | 0.520 |
Why?
| | Signal Transduction | 4 | 2025 | 5223 | 0.520 |
Why?
| | Axons | 2 | 2018 | 204 | 0.490 |
Why?
| | Mice, Inbred C57BL | 7 | 2025 | 5992 | 0.490 |
Why?
| | Mesencephalon | 1 | 2016 | 65 | 0.480 |
Why?
| | Rats, Sprague-Dawley | 6 | 2025 | 2525 | 0.450 |
Why?
| | Receptors, Dopamine D4 | 1 | 2015 | 27 | 0.440 |
Why?
| | Neostriatum | 3 | 2022 | 37 | 0.430 |
Why?
| | Motor Activity | 4 | 2025 | 718 | 0.420 |
Why?
| | Tegmentum Mesencephali | 1 | 2014 | 5 | 0.420 |
Why?
| | Analgesics, Opioid | 1 | 2023 | 1154 | 0.420 |
Why?
| | Stress, Psychological | 1 | 2022 | 1149 | 0.410 |
Why?
| | Norepinephrine | 1 | 2015 | 201 | 0.410 |
Why?
| | Nerve Net | 1 | 2017 | 286 | 0.410 |
Why?
| | Adaptation, Physiological | 1 | 2017 | 560 | 0.380 |
Why?
| | Vocalization, Animal | 4 | 2013 | 28 | 0.370 |
Why?
| | Choice Behavior | 1 | 2013 | 180 | 0.360 |
Why?
| | Goals | 1 | 2013 | 185 | 0.350 |
Why?
| | Basal Ganglia | 1 | 2011 | 57 | 0.340 |
Why?
| | Opioid-Related Disorders | 1 | 2019 | 605 | 0.330 |
Why?
| | Synaptic Transmission | 3 | 2024 | 292 | 0.320 |
Why?
| | Motor Skills | 1 | 2011 | 104 | 0.310 |
Why?
| | Extinction, Psychological | 2 | 2009 | 92 | 0.310 |
Why?
| | Association Learning | 1 | 2010 | 70 | 0.300 |
Why?
| | Movement | 1 | 2010 | 293 | 0.260 |
Why?
| | Cycloserine | 1 | 2007 | 5 | 0.260 |
Why?
| | Excitatory Amino Acid Agonists | 1 | 2007 | 42 | 0.260 |
Why?
| | Mice, Transgenic | 2 | 2025 | 2191 | 0.230 |
Why?
| | Arcuate Nucleus of Hypothalamus | 1 | 2025 | 12 | 0.230 |
Why?
| | Paraventricular Hypothalamic Nucleus | 1 | 2025 | 34 | 0.220 |
Why?
| | GABA Modulators | 1 | 2025 | 11 | 0.220 |
Why?
| | Diazepam | 1 | 2025 | 33 | 0.220 |
Why?
| | Sleep Deprivation | 1 | 2007 | 206 | 0.220 |
Why?
| | Brain Mapping | 2 | 2022 | 542 | 0.210 |
Why?
| | Reaction Time | 5 | 2014 | 434 | 0.210 |
Why?
| | Receptors, GABA-A | 1 | 2025 | 137 | 0.200 |
Why?
| | Corpus Striatum | 3 | 2022 | 179 | 0.190 |
Why?
| | Receptors, Opioid, mu | 1 | 2023 | 66 | 0.190 |
Why?
| | Behavior Control | 1 | 2022 | 12 | 0.190 |
Why?
| | Risk | 1 | 2005 | 923 | 0.180 |
Why?
| | Light | 1 | 2025 | 403 | 0.180 |
Why?
| | Histological Techniques | 1 | 2022 | 39 | 0.180 |
Why?
| | Recurrence | 2 | 2019 | 1139 | 0.180 |
Why?
| | Workflow | 1 | 2022 | 183 | 0.160 |
Why?
| | Circadian Rhythm | 1 | 2025 | 513 | 0.160 |
Why?
| | Female | 8 | 2025 | 79035 | 0.150 |
Why?
| | Entopeduncular Nucleus | 1 | 2018 | 1 | 0.140 |
Why?
| | Analysis of Variance | 3 | 2012 | 1300 | 0.140 |
Why?
| | Ultrasonics | 3 | 2013 | 50 | 0.140 |
Why?
| | Synaptic Vesicles | 1 | 2018 | 40 | 0.140 |
Why?
| | Preoptic Area | 1 | 2017 | 8 | 0.130 |
Why?
| | Glutamate Decarboxylase | 1 | 2018 | 165 | 0.130 |
Why?
| | Tissue Distribution | 1 | 2018 | 335 | 0.130 |
Why?
| | Heterogeneous-Nuclear Ribonucleoproteins | 1 | 2017 | 18 | 0.130 |
Why?
| | Leukemia, Myeloid | 1 | 2017 | 48 | 0.130 |
Why?
| | Gene Expression Regulation, Leukemic | 1 | 2017 | 56 | 0.120 |
Why?
| | Administration, Oral | 1 | 2019 | 867 | 0.120 |
Why?
| | Callithrix | 1 | 2016 | 10 | 0.120 |
Why?
| | Pars Compacta | 1 | 2016 | 4 | 0.120 |
Why?
| | Tyrosine 3-Monooxygenase | 1 | 2016 | 72 | 0.120 |
Why?
| | Head Movements | 2 | 2013 | 37 | 0.120 |
Why?
| | Anxiety | 1 | 2023 | 1122 | 0.120 |
Why?
| | Vesicular Monoamine Transport Proteins | 1 | 2015 | 9 | 0.110 |
Why?
| | Dopamine Antagonists | 1 | 2015 | 26 | 0.110 |
Why?
| | Risk Assessment | 1 | 2005 | 3752 | 0.110 |
Why?
| | Dopamine Agonists | 1 | 2015 | 41 | 0.110 |
Why?
| | Isoxazoles | 1 | 2015 | 56 | 0.110 |
Why?
| | Dopamine Plasma Membrane Transport Proteins | 1 | 2015 | 59 | 0.110 |
Why?
| | Olfactory Tubercle | 1 | 2014 | 1 | 0.110 |
Why?
| | Excitatory Amino Acid Antagonists | 1 | 2014 | 108 | 0.100 |
Why?
| | Electrophysiology | 2 | 2014 | 218 | 0.100 |
Why?
| | Microelectrodes | 1 | 2014 | 49 | 0.100 |
Why?
| | Sex Factors | 1 | 2019 | 2110 | 0.100 |
Why?
| | Electrodes, Implanted | 1 | 2014 | 114 | 0.100 |
Why?
| | Calbindins | 1 | 2013 | 6 | 0.100 |
Why?
| | Piperidines | 1 | 2015 | 222 | 0.100 |
Why?
| | S100 Calcium Binding Protein G | 1 | 2013 | 8 | 0.100 |
Why?
| | Neurotensin | 1 | 2013 | 14 | 0.100 |
Why?
| | RNA-Binding Proteins | 1 | 2017 | 447 | 0.100 |
Why?
| | Locomotion | 1 | 2014 | 101 | 0.100 |
Why?
| | Hypothalamus | 1 | 2014 | 163 | 0.100 |
Why?
| | Amphetamine | 1 | 2013 | 38 | 0.090 |
Why?
| | Substance P | 1 | 2013 | 38 | 0.090 |
Why?
| | Dose-Response Relationship, Drug | 3 | 2013 | 2028 | 0.090 |
Why?
| | Piperazines | 1 | 2015 | 375 | 0.090 |
Why?
| | Subthalamic Nucleus | 1 | 2013 | 84 | 0.090 |
Why?
| | Probability | 1 | 2012 | 308 | 0.090 |
Why?
| | Satiety Response | 1 | 2011 | 11 | 0.080 |
Why?
| | Models, Biological | 1 | 2018 | 1764 | 0.080 |
Why?
| | Habits | 1 | 2010 | 52 | 0.080 |
Why?
| | Orientation | 1 | 2010 | 50 | 0.080 |
Why?
| | Magnetic Resonance Imaging | 1 | 2022 | 3915 | 0.070 |
Why?
| | Electroshock | 1 | 2009 | 146 | 0.070 |
Why?
| | Evoked Potentials | 1 | 2010 | 131 | 0.070 |
Why?
| | Head | 1 | 2010 | 123 | 0.070 |
Why?
| | Freezing Reaction, Cataleptic | 1 | 2007 | 27 | 0.070 |
Why?
| | Sleep, REM | 1 | 2007 | 44 | 0.060 |
Why?
| | RNA, Messenger | 1 | 2015 | 2805 | 0.060 |
Why?
| | Psychomotor Performance | 1 | 2009 | 324 | 0.060 |
Why?
| | Humans | 7 | 2020 | 145763 | 0.060 |
Why?
| | Drug Administration Schedule | 1 | 2007 | 782 | 0.060 |
Why?
| | Receptors, N-Methyl-D-Aspartate | 1 | 2007 | 229 | 0.060 |
Why?
| | Suprachiasmatic Nucleus | 1 | 2025 | 19 | 0.060 |
Why?
| | Learning | 1 | 2009 | 444 | 0.060 |
Why?
| | United States Environmental Protection Agency | 1 | 2005 | 28 | 0.060 |
Why?
| | Meta-Analysis as Topic | 1 | 2005 | 173 | 0.050 |
Why?
| | Photic Stimulation | 1 | 2025 | 264 | 0.050 |
Why?
| | Melatonin | 1 | 2025 | 163 | 0.050 |
Why?
| | Pain | 1 | 2009 | 791 | 0.050 |
Why?
| | Receptors, Dopamine D1 | 1 | 2022 | 34 | 0.050 |
Why?
| | In Situ Hybridization, Fluorescence | 1 | 2022 | 328 | 0.040 |
Why?
| | Disease Models, Animal | 1 | 2011 | 4568 | 0.040 |
Why?
| | Prefrontal Cortex | 1 | 2022 | 336 | 0.040 |
Why?
| | Research Design | 1 | 2005 | 1139 | 0.040 |
Why?
| | Leukemia, Biphenotypic, Acute | 1 | 2017 | 4 | 0.030 |
Why?
| | Myeloid Progenitor Cells | 1 | 2017 | 16 | 0.030 |
Why?
| | Hematopoiesis | 1 | 2017 | 193 | 0.030 |
Why?
| | Neurotransmitter Agents | 1 | 2016 | 84 | 0.030 |
Why?
| | Behavior | 1 | 2016 | 90 | 0.030 |
Why?
| | RNA, Small Interfering | 1 | 2017 | 638 | 0.030 |
Why?
| | Cell Survival | 1 | 2017 | 1103 | 0.030 |
Why?
| | Xenograft Model Antitumor Assays | 1 | 2017 | 936 | 0.030 |
Why?
| | Pleasure | 1 | 2013 | 18 | 0.020 |
Why?
| | Stereotyped Behavior | 1 | 2013 | 21 | 0.020 |
Why?
| | Homeodomain Proteins | 1 | 2017 | 523 | 0.020 |
Why?
| | Reinforcement Schedule | 1 | 2012 | 25 | 0.020 |
Why?
| | Sweetening Agents | 1 | 2012 | 57 | 0.020 |
Why?
| | Video Recording | 1 | 2012 | 219 | 0.020 |
Why?
| | Central Nervous System Stimulants | 1 | 2013 | 185 | 0.020 |
Why?
| | Mice, Knockout | 1 | 2017 | 3130 | 0.020 |
Why?
| | Ultrasonography | 1 | 2013 | 788 | 0.020 |
Why?
| | Affect | 1 | 2010 | 321 | 0.020 |
Why?
| | United States | 1 | 2005 | 16123 | 0.020 |
Why?
| | Predictive Value of Tests | 1 | 2012 | 2123 | 0.020 |
Why?
| | Retrospective Studies | 1 | 2005 | 17325 | 0.020 |
Why?
| | Substance-Related Disorders | 1 | 2016 | 1102 | 0.010 |
Why?
| | Depression | 1 | 2016 | 1557 | 0.010 |
Why?
|
|
Root's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|